当前位置: X-MOL 学术Nat. Rev. Drug. Disc. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Digital health technologies in clinical trials for central nervous system drugs: an EU regulatory perspective
Nature Reviews Drug Discovery ( IF 122.7 ) Pub Date : 2020-09-29 , DOI: 10.1038/d41573-020-00168-z
Valentina Mantua , Celso Arango , Pavel Balabanov , Florence Butlen-Ducuing

Digital health technologies have the potential to help address some of the challenges in the clinical development of drugs for central nervous system disorders. This article discusses strategies for the development of such tools in the context of the European regulatory environment.

中文翻译:

数字健康技术在中枢神经系统药物临床试验中的应用:欧盟监管观点

数字医疗技术有潜力帮助应对中枢神经系统疾病药物临床开发中的一些挑战。本文讨论了在欧洲监管环境下开发此类工具的策略。
更新日期:2020-09-29
down
wechat
bug